May 7, 2026 — Bayer has announced positive topline results from the Phase III REVEAL study, an investigator-initiated ...
May 1, 2026 — Retia Medical recently announced the first public presentation of results from its non-invasive cardiac ...
May 6, 2026 — Image Analysis Group (IAG), a global imaging CRO headquartered in London, U.K., and HeartcoR Solutions ...
Venous thromboembolism (VTE), and pulmonary embolism (PE) in particular, are among the most complex and dangerous acute ...
The clinical case for combining CT and angiography in a single workflow has been settled. Purpose-built mobile imaging ...
May 4, 2026 — Johnson & Johnson recently announced new data from a novel U.S. pilot single-arm trial that evaluated the ...
May 4, 2026 — A new guideline from the American Society of Echocardiography (ASE) provides guidance for cardiovascular ...
Sponsored Content — According to the American Heart Association, cardiovascular disease is the leading cause of death in ...
Could a link between the heart, brain and immune system help reduce the occurrence of heart attacks and lessen the ...
April 29, 2026 — Agitated Solutions, Inc.(ASI) has received CE Mark approval in the European Union for its novel device ...
Editor's Note: This is Part Two of a three-part series highlighting several of the presentations from the American ...
Cardiac PET/CT represents a major advancement in cardiovascular diagnostics, offering significant clinical and ...
April 28, 2026 — Abbott has received U.S. Food and Drug Administration (FDA) clearance and CE Mark for its next ...
April 26, 2026 — New results from the multicenter catheter ablation versus anti-arrhythmic drugs for Ventricular ...
April 24, 2026 — University of Texas Health Science Center at Houston (UTHealth Houston) has established the Department ...
SPONSORED CONTENT — Studycast is a comprehensive imaging workflow system that allows healthcare professionals to work ...
April 27, 2026 — Banner Health recently announced it has reached a major milestone completing more than 50 total ...
April 24, 2026 — Johnson & Johnson recently announced the initiation of the PERSIGMA randomized controlled trial (RCT) ...
April 24, 2026 – Findings from the North American COVID-19 Myocardial Infarction (NACMI) registry demonstrate ...
May 07, 2026
